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Our New Job Description  
Annette Thomas, CEO, Macmillan 
The following is a transcription of a live presentation at the 
2012 Charleston Conference on November 8, 2012. Video 
of the session is available on the Charleston Conference 
website at http://katina.info/conference/ 
video_2012_thomas.php. 
I'd like to start by telling you a little bit about 
Macmillan because, like all companies, it's 
completely obvious on the inside and a little less 
obvious on the outside. Macmillan is an 
international publishing group. It was founded in 
1843 by Daniel and Alexander Macmillan in 
Scotland. In 1869, they founded Nature, and the 
scientific journal Nature, actually came out of the 
tobacco salons of the 1850s and ‘60s in London 
where intellectuals would gather to discuss the 
latest scientific and literary topics of the day. So, it 
was the Macmillan family that actually founded 
Nature in 1869. Since then, obviously, there's 
been a huge amount of development for 
Macmillan, and we are a company that spans, we 
say, two different types of publishing. One you see 
represented on the slide; that’s our science and 
our education publishing. We also have a 
consumer book publishing division, which I won't 
be speaking about today. So, we are science, 
scholarly, and educational publishers. On the 
education side, we tend to focus mainly on English 
language teaching all around the world, 
particularly in Latin America where we are very, 
very strong, and in India and China. We also have 
higher education publishing as well here in the US 
and around the world. Today, my talk is going to 
focus quite a bit on our scientific publishing out of 
Nature Publishing Group and Digital Science. We 
also have a very vibrant humanities and social 
science publishing unit, Palgrave Macmillan, and I 
will refer to that just briefly.  
Before I go into the main part of my talk today, 
I've been asked to tell you a little bit about myself, 
which is not something I usually do, so please do 
bear with me. I joined Macmillan 19 years ago, 
now almost 20 years ago, after finishing my PhD. I 
did an undergraduate at Harvard in biochem and 
biophys, and I did my graduate work at Yale 
studying the cell biology of a neuron. Most of you 
know that graduate programs in the states tend to 
be quite lengthy affairs, and mine was no 
exception. My PhD took me six years to finish at 
Yale, and at about year number two, I decided this 
was great fun, and we were actually having great 
fun, and we were publishing well, including 
publishing in Nature, but I decided that I would try 
and find something that I could do with my 
research background that wouldn't necessarily be 
research, and what I have realized over the years 
is that I think I made the right decision, but being 
quite a young person then, I probably made the 
right decision for all of the wrong reasons, as 
often happens. But I finished my PhD and at the 
end of that, it was 1993, I had the opportunity to 
join Nature as an editor. So, just to give you a bit 
of context, 1993 was just the beginning of digital, 
insofar as e-mails and servers and things like that, 
well it was for most companies. It wasn't for 
Nature Publishing Group. It was also, I think, when 
scientific publishing was really starting to enter 
into a new phase; it was becoming more 
competitive, even for publications like Nature. So, 
I joined them in London as an assistant editor, so 
my job was to select the manuscripts and see 
them through peer review in the areas of cell 
biology and neuroscience, and I did that for a 
couple of years, and it was a fantastic job, 
particularly for someone just finishing up their 
graduate work. We were exposed to a lot of 
different science, a lot of different scientists—
incredibly exciting. And in the years that followed, 
I had a number of different roles at Nature. I 
launched Nature Cell Biology. I was the editor of 
that title when we launched that in 1999. I held 
some commercial positions in between. I was the 
publisher of the Review journals which we 
launched in 2000, Nature Reviews. We now have 
several titles under that banner. So, we launched 
the Review journals in 2000, and just after that I 
was appointed the managing director of Nature 
Publishing Group, and that's really when our 
phase of digital development began, setting up 
our Nature.com platform, site license program, 
the many different business models we tried. I'm 
sure there are people in the room that have as 
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fond memories of that time as I do. And over that 
period, then we started to expand more rapidly 
the Nature brand into new research journals, and 
our academic publishing became a bigger part of 
what we were doing. And we had several different 
innovations that we were creating through our 
web team which has actually evolved into Digital 
Science. We will talk a bit about that, but in 2007, 
I was then appointed Chief Executive of 
Macmillan, which is the parent company of 
Nature Publishing Group, and I have held that role 
for five years. So, I stand here as the Chief Exec. of 
a medium-sized publishing company. We are still 
family-owned. In ‘95 the Macmillan family decided 
to exit publishing and they found an excellent 
home for Macmillan. They were looking for a 
home that would keep Macmillan “Macmillan,” 
and not separate it up into its component parts, 
and they found that home with the Holtzbrinck 
Media Group, which is based out of Germany, and 
we've been part of Holtzbrinck since 1995, and 
that has indeed been a very good home for 
Macmillan. We are still family-owned, and I say 
that because it gives us a certain perspective on 
what we do, and I think you'll see some of that 
come out in the rest of my talk.  
We're very, very focused on science education; it's 
the main area of focus for us. We take a very long-
term view of what we're doing and trying to 
evolve our business, because we feel that we have 
an obligation to all of our customers: our 
researchers, our scholars, our professors, our 
teachers, our students, to evolve over the long 
term and not look for short-term solutions to 
long-term issues. And that's a little bit about our 
company; it's a little bit about me. Scientific 
background, scientist at heart, I still have not 
managed to find the time to go off and do an MBA 
or a mini-MBA, so I have a lot of people who 
support me in a lot of the different things that I 
do, and it's my pleasure to now move into the 
main part of my talk where I will be able to share 
with you our perspective on how publishing’s 
evolving and a little bit of the hard work that 
they've been doing over the last couple of years. 
So, I'm going to talk quite a bit about science 
today, and when we think about how publishing is 
evolving, we think first and foremost about the 
scientist, and I know that sounds really obvious, 
but many publishers operate in what we would 
call a “B2B” kind of market, and that means they 
are very focused on, not necessarily the end 
customer, but the products and how those 
products are ultimately going to go into the 
market. We try and take a really customer-
oriented approach and always remember that we 
are here to try and make scientists and the 
scientific research process more effective and 
more efficient, and when you put on that hat, 
when you take that perspective, what we can do 
as publishers actually expands far beyond what 
we would call traditionally publishing discoveries. 
Of course, that is an important part of the 
scientific process. It is very important to scientists 
to be able to communicate the findings, record 
their findings, and get credit for their findings; but 
particularly now with the evolution of digital 
technologies, there are many, many more ways 
that we can think about how we can help make 
that scientific research process more effective, 
more efficient, more successful.  
Learning about discoveries is the process the 
scientists increasingly have to grapple with and 
spend a lot of their time on. What's important to 
me as a scientist in my particular field? Who is 
important to me? Why is it important to me? How 
do I keep up to date with the increasing deluge of 
information that's coming at me from all different 
angles? How do I plan my experiments? I may 
know what I want to do, but how do I know the 
best way to do it? What's going to give me the 
best chance of success?  
Actually doing the experiments is also 
increasingly, particularly in labs that are now 
much, much more interdisciplinary than they used 
to be, quite a challenge for scientists. Evaluating 
the results, sharing the results; sharing the results 
is not just about publishing your results. I was 
thinking about who in my community and beyond 
will be interested in these results and how do I 
best get them that information. At the very top of 
the slide you can see there is a slightly lighter 
circle which is really more about the scientists 
themselves. So, after I publish, how do I gain and 
grow and enhance my reputation? How do I 
obtain funding, obtain collaborators, so that I can 
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grow my lab, so I can do more experiments, and 
continue the cycle of success? When we think 
about how we want to evolve what we do, we 
very much have this picture in mind and we call 
them “pain points.” What are the pain points the 
scientists have that are keeping them from being 
as successful as they would like to be, and what 
can we do, not necessarily on our own, often in 
collaboration with others, to address those pain 
points?  
I'm going to share with you a few of the projects 
that we’re working on, and there’s other groups 
out there, some attending the conference over 
the next couple of days, that also working on 
some of these problems. So by no means do I 
think we have all the answers, but we're trying 
some approaches that I hope you'll find of 
interest. 
So, publishing discoveries, you might say “there's 
nothing new here.” We've been publishing 
discoveries since science began, certainly even 
before Nature was launched. But publishing 
discoveries has changed. We all know that 
business models, new business models, have been 
introduced, open access, author processing 
charges, Green OA, Gold OA, there's a lot of new 
types of business models, and Nature Publishing 
Group is also embracing that. Nature 
Communications was a journal that we launched 
some 2+ years ago. It has a mixed business model 
with subscriptions but also with open access. 
Scientific Reports was launched more recently. 
That's a purely open access journal with author 
and funder charges.  
But the business models are not the only thing 
that's changing. It's also how scientific research is 
actually communicated and published that’s 
changing. In 2001, Nature published the Human 
Genome. That was a seminal, seminal research 
paper. Three billion nucleotides sequenced. I 
didn't bring it with me because I had only carry-on 
luggage knowing the transportation challenges of 
getting from London to Charleston with the storm 
and everything else, but had I brought it with me, 
I would be showing you now “2001: The Human 
Genome,” a telephone book-like directory which 
recorded the three billion nucleotides that were 
sequenced by the Human Genome Project. Last 
month, Nature and two other publishers 
published “The End Code Project.” Now, this is 
really interesting because of those three billion 
nucleotides, only 1.2% encoded genes, so what 
are the other nucleotides doing? In 2003, the End 
Code Project was kicked off to answer that 
question. What are these gene deserts for? Do 
they do anything? Some of you might be familiar 
with the term junk DNA. Well, is it really junk 
DNA?  
What we found out last month in the publication 
of the End Code Project is that it's not junk DNA. 
Eighty percent of that DNA is actually encoding 
regulatory elements, promoter elements, and it's 
there that our uniqueness comes. We have more 
diversity in that so-called “junk DNA” that's 
regulating our genes than we do in our genes 
ourselves. This is a really important discovery. 
Now that we know that 70% of the nucleotides 
have these important functions, we just have to 
figure out what they actually regulate.  
But it's not just science that has moved on. Also, 
how it's published has moved on. “The End Code 
Project” is not a telephone book directory of 
nucleotides. “The End Code Project” was 
published last month completely open, in 
collaboration between three publishers, and in 
this unique format that you see on the slide at the 
bottom, the bottom left in the black, it sort of 
comes out where there’s these threads where 
we’ve connected the main concepts the scientist 
will want to know about this project; he can click 
on each bubble and the threads come up leading 
the scientists to the relevant papers. Once he goes 
into those research papers, much of the data can 
be actively mined and interrogated on the spot by 
the readers. This is a very different approach than 
in 2001, so, it's not just business models that are 
changing; it's how publishing is actually changing. 
And whilst today's talk is mainly about science and 
scientific research, it's also changing in the 
humanities and social sciences. 
In Palgrave Macmillan we announced earlier this 
year Palgrave Pivot, and on the surface this seems 
like a very straightforward concept, but within 
HSS it’s been warmly embraced. What is Palgrave 
Pivot? Humanities and social science scholars 
have two types of formats, and you all will know 
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this. They have the journal format, short format, 
and they have the monograph too, long format. 
But that's a very sort of physical world-type 
constraint. Palgrave Pivot brakes open those 
boundaries, allowing the scholars to publish at 
whatever length suits their research, but it also 
introduces new and flexible business models into 
the HSS space which have yet to really take hold. 
So, there's innovation and publishing around 
business models, around how publishing is 
happening, around mining data. This isn't 
yesterday's type of publishing. It's very much 
today and into the future. 
Learning about discoveries: again, the information 
overload problem. Traditionally, scientists would 
have turned to content such as Nature Reviews 
and Scientific American, also in our stable, and 
they still do. These types of seminal pieces of 
work provide really useful overviews for readers. 
But there is a new type of way to keep up-to-date, 
and before I go into this just to refer to some 
experiences I had recently.  
Just last week, I spent the week in the Bay Area in 
San Francisco, and we visited UC Davis, UC 
Berkeley, UCSF, and Stanford over three or four 
days. We met with graduate students. We met 
with post docs. We met with PI’s. We met with 
librarians. We met with professors, teachers, and 
students, talking about all manners of issues 
around scientific research, around peer review, 
around publication, business models, Prop 30, 
which did pass in the election, which is great 
news; a lot of different issues in a very challenging 
market.  
For me it was one of the most interesting visits 
that I've had in some time, particularly around the 
graduate students, and listening to them, how 
they keep up-to-date with information. It's 
certainly not how I kept up-to-date with 
information when I was in grad school. They are 
mining the social web. They are mining Facebook, 
Twitter, and social media. They are interacting 
with their colleagues. They are using, yes, 
traditional table of content alerts as well, but it's a 
much richer way of mining information and 
keeping up-to-date. And my belief is that, going 
forward, well, there's not going to be one way, 
there’s no magic bullet that will keep you up-to-
date as a scientific researcher, but it will be a 
combination of tools that will be used and that 
will involve technology and algorithms and search. 
It will involve user-generated content as well, and 
ultimately, I think, in some cases it will also 
involve that editorial overlay that we are so 
familiar with, that quality control. We're 
developing several tools in this area, and I just 
have a couple to tell you about today.  
So, altmetrics: there is an altmetric movement 
afoot, and by altmetric I mean alternative ways to 
measure impact, to measure relevance. There is a 
disbursed conversation going on online as we 
speak about scientific research. In the social web, 
right now articles are being discussed and being 
debated all over the place. But how do you track 
that? If it's your research, you’re interested. If it's 
research that you should know about, you're also 
interested, and you’ll want to join the 
conversation. Altmetric is a tool that allows you to 
do that. It tracks article research, articles being 
mentioned in Facebook, in Twitter, in blogs, but 
also in the mainstream media: BBC, New York 
Times, CNN, Scientific American; and it allows 
scientists to track the research they're most 
interested in, and obviously join in on that 
conversation should they wish to do so. 
Increasingly this is an important measure of 
impact. Impact isn't something necessarily that's 
just cited and measured two years later, the kind 
of impact we’re all familiar with. It's the impact 
were having right now. Any of us in this room 
could be having that type of impact, and Altmetric 
is a tool that allows scientists to track that and to 
participate in that. It tracks over two and a half 
thousand sources. It's three million papers and 
growing and has already over five million social 
media mentions. 
So, ReadCube is another tool that we've 
developed, and ReadCube does a couple of things. 
It helps scientists organize their PDF collection. I 
mean, did you ever stop to think that scientists 
have better tools to organize their music and their 
photos than they do their PDFs? It's quite 
something. But not only does it allow a scientist to 
organize their PDFs, it also allows them to 
annotate and find it again with a powerful search 
tool. It also, really importantly, allows them to 
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discover new research, because ReadCube is a 
tool that the more you use it, the smarter it gets, 
and it will send you personalized alerts on the 
content, not that you already know about, but the 
content that should be of interest to you based on 
what you're already storing and what you’re 
reading. I have to just a short video here too 
(Video available online at http://www.readcube.com 
/#features, accessed 1/14/13). 
So, those of you with particularly good hearing, 
perfect pitch, will realize that that was my voice 
doing the voice over, so, you know, we all muck in 
together at Macmillan. That's a little bit about 
ReadCube, but it goes a bit beyond that. In the 
last month we started a pilot with Rick Anderson 
and his colleagues at University of Utah to use 
ReadCube to allow their patrons to access content 
that they don't already have site license 
subscriptions to, and that means that the 
researchers at University of Utah can go in 
through ReadCube and purchase at very, very 
affordable prices, not just access to the content, 
but access to the rich PDF format of ReadCube, 
which you just saw, and they can rent that 
content by the day or longer. They can read it 
online; the prices are very, very affordable, lower 
than the usual one-time access fees. The only 
thing they can’t do with it at the moment is to 
print it or to share it, so it's a different type of 
access business model which makes it more 
affordable and richer. Off the back of this pilot 
today, actually, my colleagues here in Charleston 
are announcing that all of the Nature content now 
will be available through ReadCube for purchase 
and access in this multiple of ways and using the 
rich ReadCube format. I think they're hosting the 
party tonight at six, so if any of you are interested 
in learning more about ReadCube, do take a look 
and take it up with them directly, because they 
are the experts. 
So, planning experiments. This is what we might 
generously call an information rich environment. 
Before I was a scientist, when I was still a young, 
young, young person and reading Scientific 
American, I had this image of what a lab would 
look like, and this wasn't it, but this was very 
much what the lab that I worked in looked like, 
and I can tell you, I was visiting labs last week, and 
things haven't really changed. Scientists need help 
in order to organize their laboratory environment. 
We're talking about consumable samples, data 
sets, shared equipment, and protocols. How 
would you go about organizing your lab? How do 
you organize your stuff? And by the way, when 
that postdoc leaves, and six months later he's 
gone, you need to find out where his protocols, 
where his samples, where his consumables were 
because you're going to need to be able to build 
on and reproduce those experiments. How do you 
do that in a lab? Labguru is one tool that we’ve 
developed that helps scientists organize their 
stuff, and if they can organize their stuff better, 
they can spend less time on that and more time 
making the big discoveries.   
1DegreeBio takes a different approach. It’s 
essentially a marketplace for consumables in 
science where scientists can rate and rank and 
share their experiences. In the first instance it 
started around antibodies, because antibodies are 
a huge part of much of the molecular biology 
research that is done, but it is extending now 
beyond that to include all aspects of consumables 
in labs. These are two different ways of trying to 
really help scientists record what they're doing 
and organize themselves, but also be more 
effective at planning their experiments in the first 
place. 
What about doing experiments? Okay, so 
compliance is not the sexiest topic in the world, 
but increasingly when you're on campus, 
campuses have to be run in a professional way. 
Compliance is a part of all of our lives. But 
compliance in a lab, if you think compliance in a 
lab 20 years ago versus compliance now, it's 
completely different. BioRAFT is a tool that helps 
scientists, and particularly helps departments, 
organize their compliance programs: their 
training, their paperwork, that they have a record 
that they are actually setting themselves up to do 
the experiments in a proper way. 
Okay, sharing results. So sharing results is not, 
these days, just about publishing a paper. 
Scientists do a lot of research, and a lot of it 
never, ever gets published; and even research 
that does get published, if you publish genes, or if 
you publish proteins, then it is very obvious where 
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you should store your data. But most of the 
research that is published, and most of the 
research that’s unpublished, there's nowhere to 
store that data. Why would you want to store the 
data? Well, you would want to store the data 
because you want to retrieve it at some point, but 
actually you want to store that data and make it 
available because you want to share it, you want 
to get credit for the work that you've done, the 
work that you've done that doesn't have a natural 
home in one of the big existing databases, or the 
work that you've done that’s perhaps had a 
negative result, and most science is negative 
results.  
Figshare is a tool that's been developed that 
allows scientists to do just that. They can store 
their data, they can make it available to others, 
it’s citable, and it’s trackable, so that they can get 
credit. Some of the statistics on Figshare—at the 
moment, it has thousands and thousands of 
different types of data sets that have been 
downloaded, and the usage of Figshare now 
extends to countries all over the world and some 
of the top labs all the way to some of the smaller 
labs. We're trying to solve the problem of what 
you do with data that normally would sit in your 
cupboard or sit on your computer, making that 
discoverable, making that trackable, making it 
citable.  
So, that's a little bit about some of the things that 
we are working on at Macmillan, at Nature 
Publishing Group, and Digital Science, in 
particular. I'm often asked, in fact, we have a lot 
of debate in our company, “What makes a service 
or a solution indispensable? What makes it really 
indispensable? When you look at that map what 
makes something really a must-have?” I have four 
characteristics that I look for, and not every tool 
or service or solution that we think of ticks all of 
these boxes, but these are things that I think are 
important.  
First of all, it has to demonstrably and measurably 
improve an outcome. Not just because I say it 
does or the marketing material says that it does, 
but we have to be able to measure that improved 
outcome. Second, it should be global and set a 
global standard. If we can introduce more global 
standards, for example, around the way that we 
store data, it makes it much easier for others to 
do the same, but also to build applications off the 
back of it. Third, I'm doing this now from memory, 
it should contribute to and benefit from network 
effects, so the more that that tool is used, the 
smarter it becomes; the more valuable it is for me 
as the user, the more valuable it becomes for all 
the users. And I'm thinking of number four, which 
will come to me.  
When we look at this map, I'm often asked “What 
is the business model?” Now this was the topic of 
conversation last week. “What is the business 
model?” Well, the fact is that the business model 
is different for different parts of this particular 
landscape, and what I look for, what we look for 
as a group, is we look for the entire ecosystem to 
be commercially sustainable in the long term. 
Some of the things that we focus on and we 
produce, we do that because it generates a 
network effect. It draws users in; it's valuable to 
them. Other things that we produce actually 
retain our users within the network and other 
things that we do, in and of themselves, will 
generate revenue. But it’s that rich ecosystem 
that we are looking to establish that needs to be 
commercially sustainable for the long term. Why 
does it need to be commercially sustainable for 
the long term? Well most importantly, for me, it 
needs to be commercially sustainable because we 
want to be able to continue to invest in the 
future, and also as a medium-sized privately held 
company, we want to be certain that we always 
have that bandwidth to keep investing for the 
future. And so for us it’s the mix. It’s the mix of 
everything that we do together that has to be 
commercially sustainable. That gives us a huge 
amount of flexibility, I think, and freedom to 
experiment, to think creatively and innovatively 
about how we’re going to pull these various 
services together. So there's not one business 
model; it's not one-size-fits-all. It really depends 
on how the various services that we produce 
interact together.  
So, going back to my four indispensables, I said 
that it should be global, and set global standards, 
that it should have demonstrably measurable 
outcomes, that it should create and benefit 
network effects and now I'm just trying to think of 
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the last one, and I'm jetlagged. Apparently I'm 
going to be interviewed later this afternoon, so for 
any of you who are really, truly interested. Now I'll 
get to measure your interest in my talk, if you 
really want to know what number four is, because 
that's the kicker I'm sure, that's the magic dust, 
then by all means do follow it up in the interview.  
It has been an enormous pleasure for me to share 
with you a little bit with you of what we're doing 
at Macmillan. We do not have all the answers, and 
we don't operate on our own within our company, 
but we have many collaborators in the library 
community, in the scientific community, with 
other companies. I'm not presenting this as the 
answer. It's going to be a very rich answer with 
contributions coming from a lot of different 
places, I'm sure. But this is a little bit about what 
we're doing and a little bit about our approach. 
Last week, when I was at UCSF, the Provost said to 
me “Ah, publishers. I feel sorry for you guys,” and 
we then went on to have a conversation about 
some of the issues he was interested in, some of 
the challenges he was interested in, and at the 
end of it he realized that he's interested in exactly 
what we're interested in.  
I'm completely optimistic for the future of 
publishing, and I'm optimistic because there's so 
much more to do now than there was 20 years 
ago. Twenty years ago we spent most of our time 
on the publishing discoveries, and whilst that will 
always remain important, there is now a very rich 
landscape that digital technology allows us to 
really, truly think innovatively and creatively 
about. So I am very optimistic. And in a funny way, 
I can see that the librarian community and what 
you all do is very much aligned with this as well. 
We both have the same goal, which is to make 
scientists and the scientific research process more 
effective, more efficient, more successful. But 
we're both at a much, much richer landscape, and 
that provides a lot of challenges but also a lot of 
opportunities for how we might go about doing 
that, and I very much hope that we can work on it 
together in the months and years to come 
because this is an exciting place to be.  
There is a huge amount of opportunity here. It's 
not easy, but it's definitely there. So Accentuate 
the Positive, I believe, is the theme of the 
conference. I believe there is a huge amount of 
positive, absolutely, and anyone who is coming 
into publishing today, or anyone that is coming 
into information sciences today, really has the 
world as their oyster. Thank you very much for 
inviting me. 
 
 
 
 
 
 
 
  
